These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 19076292

  • 1. Increased coated-platelet levels in chronic haemodialysis patients.
    Valaydon ZS, Lee P, Dale GL, Januszewski AS, Rowley KG, Nandurkar H, Karschimkus C, Best JD, Lyons TJ, Jenkins AJ.
    Nephrology (Carlton); 2009 Apr; 14(2):148-54. PubMed ID: 19076292
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
    Healy H, Reith D, Morgan C, Clague A, Westhuyzen J.
    Ann Clin Lab Sci; 2000 Jul; 30(3):295-304. PubMed ID: 10945571
    [Abstract] [Full Text] [Related]

  • 5. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
    Flisiński M, Strózecki P, Stefańska A, Zarzycka-Lindner G, Brymora A, Manitius J.
    Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients.
    Locatelli F, Andrulli S, Memoli B, Maffei C, Del Vecchio L, Aterini S, De Simone W, Mandalari A, Brunori G, Amato M, Cianciaruso B, Zoccali C.
    Nephrol Dial Transplant; 2006 Apr; 21(4):991-8. PubMed ID: 16384825
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD, Petrasch M, Rauh M, Stöhr W, Nüsken E, Schneider H, Dötsch J.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [Abstract] [Full Text] [Related]

  • 11. Serum and cellular interleukin-6 in haemodialysis patients: relationship with energy expenditure.
    Kamimura MA, Draibe SA, Dalboni MA, Cendoroglo M, Avesani CM, Manfredi SR, Canziani ME, Cuppari L.
    Nephrol Dial Transplant; 2007 Mar; 22(3):839-44. PubMed ID: 17205966
    [Abstract] [Full Text] [Related]

  • 12. Assessment of lipid dysfunction in patients on maintenance haemodialysis.
    Altaf A, Halim A, Khan DA, Khalid M, Fatima-Tuz-Zuhra, Saif I.
    J Ayub Med Coll Abbottabad; 2007 Mar; 19(4):32-6. PubMed ID: 18693593
    [Abstract] [Full Text] [Related]

  • 13. Effects of smoking and blood eosinophil count on the development of arteriovenous fistulae thrombosis in hemodialysis patients.
    Ozdemir FN, Akcay A, Bilgic A, Akgul A, Arat Z, Haberal M.
    Transplant Proc; 2005 Sep; 37(7):2918-21. PubMed ID: 16213261
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. T-cell subset counts and serum immunoglobulin concentrations in patients with chronic renal failure at the Kenyatta National Hospital.
    Gogo KO, McLigeyo SO, Bwayo JJ, Mumo JM.
    East Afr Med J; 1998 May; 75(5):271-3. PubMed ID: 9746996
    [Abstract] [Full Text] [Related]

  • 16. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients.
    Sabovic M, Zupan IP, Salobir B, Zupan I, Cernelc P, Lavre J, Vujkovac B.
    Thromb Haemost; 2005 Dec; 94(6):1245-50. PubMed ID: 16411401
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the pro-thrombotic state in CAPD patients.
    Preloznik Zupan I, Sabovic M, Salobir B, Buturovic Ponikvar J.
    Ren Fail; 2008 Dec; 30(6):597-602. PubMed ID: 18661409
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
    De Vecchi AF, Bamonti F, Novembrino C, Ippolito S, Guerra L, Lonati S, Salini S, Aman CS, Scurati-Manzoni E, Cighetti G.
    Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for thromboembolic events in renal failure.
    D'Elia JA, Weinrauch LA, Gleason RE, Lipinska I, Lipinski B, Lee AT, Tofler GH.
    Int J Cardiol; 2005 May 11; 101(1):19-25. PubMed ID: 15860378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.